Prof Rod Jackson
Rod Jackson is Professor of Epidemiology and Head of Epidemiology & Biostatistics at the School of Population Health, University of Auckland, New Zealand. He is medically trained, has a PhD in Epidemiology and is a member of the New Zealand College of Public Health Medicine. He teaches epidemiology and evidence-based health care to undergraduates and postgraduates, both in New Zealand and internationally. His main research interest for over 25 years has been the epidemiology of cardiovascular diseases. He is one of the architects of New Zealand risk-based clinical guidelines for managing CVD risk and is currently leading the PREDICT programme which uses a web-based clinical decision support system to get evidence, about CVD risk and risk management, into and out of primary care practice simultaneously. He has published over 200 peer-reviewed papers.


Workshop 5 and 14 - Communicating the Real Heart Risks
Saturday, 13 June 2009 Start 11:00am Duration: 55mins
Saturday, 13 June 2009 Start 12:05pm Duration: 55mins
This workshop will explore a wide range of tools for communicating CVD risk including a new approach based on heart age. Feedback will be sought for how to improve these tools.

Presentation Handout: Communicating the Real Heart Risks (PDF Format)
CVD Risk: The Death of Diagnosis?
Sunday, 14 June 2009 Start 8:55am Duration: 25mins
 A diagnosis has traditionally involved categorising a patient as either having a disease or not. However most of the current and future burden of disease in middle and high-income countries does not fit this binary paradigm. People with vascular ‘diseases’ such as ‘hypertension’, hyperlipidaemia or diabetes (as well as depression, respiratory diseases and cancers) have a wide range of risk of morbidity and mortality, as do many people yet to be ‘diagnosed’ with one of these ‘diseases.’

For many so-called ‘diseases’ the assessment of diagnosis should be replaced by the explicit assessment of risk. Increasingly electronic risk prediction tools are replacing diagnostic aids in clinical practice. The implications are huge and will be very political as thresholds for intervention will need to be determined by payers rather than practitioners. While this is already happening to some extent, the death of clinical diagnosis and its replacement by risk prediction, will make the political nature of treatment decisions far more explicit. CVD risk prediction is leading this development and the diagnosis of vascular diseases is now of decreasing clinical relevance.

Copies of the CVD Handbook and CDROM will be available at the back of the room for Prof Rod Jackson's sessions.  Further copies can be ordered from the New Zealand Guidelines Group at  www.nzgg.org.nz/cvdhandbook

Presentation Handout: CVD Risk: The Death of Diagnosis? (PDF Format)